Patent intelligence · US
US 9900622
Multiple sign bit hiding within a transform unit
Multiple sign bit hiding within a transform unit
Patent details — US 9900622
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 20, 2018
- Expiration
- Feb 15, 2038
- Applicant
- BlackBerry Limited
- Claims
- 11
- CPC classes
- A61K, A61K31/12, A61K31/7048, A61K36/185
Quick answer
US 9900622 (Multiple sign bit hiding within a transform unit) is held by BlackBerry Limited. Status: granted. Granted Feb 20, 2018. Expires Feb 15, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BlackBerry Limited
- Grant date
- Expiration
- Claims
- 11
- CPC classes
- A61K, A61K31/12, A61K31/7048, A61K36/185, A61K36/28, A61K36/324
More from BlackBerry Limited
Related pharmaceutical patents in our USPTO index.
-
US 12343394
CD38 modulating antibody agents
granted -
US 12325699
Antibacterial compounds
granted -
US 12304964
CD38 modulating antibody
granted -
US 12187754
LpxC inhibitors and uses thereof
granted -
US 12161717
CD38 modulating antibody agents
granted -
US 12162949
CD38 antibody
granted -
US 11897873
Kappa opioid receptor antagonists and products and methods related thereto
granted -
US 11780930
CD38 modulating antibody
granted
Frequently asked questions
What is US patent 9900622?
US 9900622 (Multiple sign bit hiding within a transform unit) is held by BlackBerry Limited. Status: granted. Granted Feb 20, 2018. Expires Feb 15, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9900622?
BlackBerry Limited is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 38 pharmaceutical patents for this assignee.
When does US 9900622 expire?
Our index shows an expiration date of Feb 15, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.